SCHEMBL3650309

SCHEMBL3650309

Cc1cc(NC(=O)CC2CCCC2)ccc1[N+]1(C2CCNC2)CCCC1C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
RAB9A P51151 4/20 0.50
MEN1 O00255 2/20 0.50
NPC1 O15118 4/20 0.42
EPHX2 P34913 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
NAMPT P43490 3/20 0.38
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3653647 0.94 KMT2A (0.45) KMT2ARAB9AMEN1NPC1EPHX2
SCHEMBL3650418 0.85 EPHX2 (0.48) KMT2ARAB9AMEN1NPC1EPHX2
SCHEMBL3658091 0.83 NPC1 (0.53) RAB9ANPC1EPHX2SMN1; SMN2TSHR
SCHEMBL3658418 0.83 NPC1 (0.48) KMT2AMEN1NPC1HPGDSMN1; SMN2
SCHEMBL3657582 0.81 HRH3 (0.41) KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL3655137 0.81 RAB9A (0.43) KMT2ARAB9AMEN1NPC1EPHX2
SCHEMBL3655153 0.81 NPC1 (0.43) KMT2ARAB9AMEN1NPC1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3650317 0.80 EPHX2 (0.43) KMT2ARAB9AMEN1NPC1EPHX2
SCHEMBL3656630 0.80 KCNK3 (0.40) ALDH1A1LMNA
SCHEMBL3652477 0.80 ESR1 (0.45) KMT2ARAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212283-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP claimed
WO-2009052062-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO claimed
EP-2212283-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052062-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed